Members Only
Poster
Adapting to a Pandemic: A Systematic Review of COVID-19 Consideration and Reporting in Phase III Oncology Trials Research Poster
This research examines whether cancer clinical trials were prepared to account for COVID-19 as an unexpected clinical disruption. Using data from Phase III RCTs, we analyze how COVID-19 was incorporated into trial protocols and how consistently COVID-related toxicities were later reported.
Like
Be the first to like this